Zimmer Biomet Holdings Price to Sales Ratio 2010-2024 | ZBH
Historical PS ratio values for Zimmer Biomet Holdings (ZBH) over the last 10 years. The current P/S ratio for Zimmer Biomet Holdings as of September 19, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Zimmer Biomet Holdings P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-09-20 | 106.42 | 2.94 | |
| 2024-06-30 | 108.53 | $36.17 | 3.00 |
| 2024-03-31 | 131.69 | $35.67 | 3.69 |
| 2023-12-31 | 121.21 | $35.21 | 3.44 |
| 2023-09-30 | 111.55 | $34.64 | 3.22 |
| 2023-06-30 | 144.42 | $34.23 | 4.22 |
| 2023-03-31 | 127.94 | $33.79 | 3.79 |
| 2022-12-31 | 126.02 | $33.01 | 3.82 |
| 2022-09-30 | 103.14 | $32.78 | 3.15 |
| 2022-06-30 | 103.41 | $32.84 | 3.15 |
| 2022-03-31 | 125.61 | $32.73 | 3.84 |
| 2021-12-31 | 124.53 | $32.44 | 3.84 |
| 2021-09-30 | 143.20 | $29.73 | 4.82 |
| 2021-06-30 | 157.10 | $30.98 | 5.07 |
| 2021-03-31 | 156.15 | $28.54 | 5.47 |
| 2020-12-31 | 150.08 | $29.56 | 5.08 |
| 2020-09-30 | 132.39 | $34.10 | 3.88 |
| 2020-06-30 | 115.86 | $33.99 | 3.41 |
| 2020-03-31 | 97.91 | $37.71 | 2.60 |
| 2019-12-31 | 144.65 | $38.67 | 3.74 |
| 2019-09-30 | 132.44 | $38.56 | 3.43 |
| 2019-06-30 | 113.40 | $38.36 | 2.96 |
| 2019-03-31 | 122.73 | $38.53 | 3.19 |
| 2018-12-31 | 99.50 | $38.79 | 2.56 |
| 2018-09-30 | 125.82 | $38.77 | 3.25 |
| 2018-06-30 | 106.45 | $38.71 | 2.75 |
| 2018-03-31 | 103.94 | $38.47 | 2.70 |
| 2017-12-31 | 114.77 | $38.32 | 2.99 |
| 2017-09-30 | 111.15 | $38.04 | 2.92 |
| 2017-06-30 | 121.62 | $38.18 | 3.19 |
| 2017-03-31 | 115.45 | $38.31 | 3.01 |
| 2016-12-31 | 97.38 | $38.02 | 2.56 |
| 2016-09-30 | 122.40 | $38.34 | 3.19 |
| 2016-06-30 | 113.11 | $37.87 | 2.99 |
| 2016-03-31 | 99.99 | $34.92 | 2.86 |
| 2015-12-31 | 95.98 | $32.06 | 2.99 |
| 2015-09-30 | 87.69 | $29.00 | 3.02 |
| 2015-06-30 | 101.74 | $26.87 | 3.79 |
| 2015-03-31 | 109.24 | $27.04 | 4.04 |
| 2014-12-31 | 105.24 | $27.24 | 3.86 |
| 2014-09-30 | 93.11 | $27.34 | 3.41 |
| 2014-06-30 | 95.98 | $27.14 | 3.54 |
| 2014-03-31 | 87.22 | $27.07 | 3.22 |
| 2013-12-31 | 85.73 | $26.98 | 3.18 |
| 2013-09-30 | 75.41 | $26.47 | 2.85 |
| 2013-06-30 | 68.63 | $26.08 | 2.63 |
| 2013-03-31 | 68.70 | $25.61 | 2.68 |
| 2012-12-31 | 60.72 | $25.33 | 2.40 |
| 2012-09-30 | 61.43 | $24.81 | 2.48 |
| 2012-06-30 | 58.31 | $24.42 | 2.39 |
| 2012-03-31 | 58.07 | $23.94 | 2.43 |
| 2011-12-31 | 48.12 | $23.31 | 2.06 |
| 2011-09-30 | 48.18 | $22.76 | 2.12 |
| 2011-06-30 | 56.93 | $22.13 | 2.57 |
| 2011-03-31 | 54.53 | $21.44 | 2.54 |
| 2010-12-31 | 48.36 | $20.82 | 2.32 |
| 2010-09-30 | 47.14 | $19.72 | 2.39 |
| 2010-06-30 | 48.69 | $19.62 | 2.48 |
| 2009-12-31 | 53.25 | $18.88 | 2.82 |
| 2009-09-30 | 48.15 | $18.95 | 2.54 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $21.656B | $7.394B |
| Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $198.609B | 25.65 |
| Stryker (SYK) | United States | $139.112B | 32.51 |
| Boston Scientific (BSX) | United States | $123.274B | 37.54 |
| Medtronic (MDT) | Ireland | $114.744B | 17.07 |
| EssilorLuxottica (ESLOY) | France | $106.116B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.707B | 34.87 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.203B | 0.00 |
| ResMed (RMD) | United States | $35.702B | 31.43 |
| Koninklijke Philips (PHG) | Netherlands | $29.054B | 22.08 |
| Terumo (TRUMY) | Japan | $28.562B | 40.34 |
| Baxter (BAX) | United States | $19.774B | 13.41 |
| Insulet (PODD) | United States | $16.665B | 70.11 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.531B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.604B | 31.82 |
| Demant (WILYY) | Denmark | $9.197B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.682B | 32.48 |
| Lantheus Holdings (LNTH) | United States | $7.537B | 18.09 |
| ICU Medical (ICUI) | United States | $4.428B | 42.25 |
| TG Therapeutics (TGTX) | United States | $3.914B | 41.44 |
| Haemonetics (HAE) | United States | $3.842B | 19.01 |
| Neogen (NEOG) | United States | $3.799B | 39.84 |
| Perrigo (PRGO) | Ireland | $3.788B | 11.97 |
| GN Store Nord (GNNDY) | Denmark | $3.691B | 22.23 |
| Prestige Consumer Healthcare (PBH) | United States | $3.663B | 18.25 |
| Envista Holdings (NVST) | United States | $3.324B | 17.73 |
| QuidelOrtho (QDEL) | United States | $3.108B | 19.59 |
| Agios Pharmaceuticals (AGIO) | United States | $2.696B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.230B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.192B | 36.79 |
| LeMaitre Vascular (LMAT) | United States | $2.026B | 54.00 |
| AdaptHealth (AHCO) | United States | $1.520B | 10.97 |
| InMode (INMD) | Israel | $1.490B | 9.49 |
| Warby Parker (WRBY) | United States | $1.483B | 0.00 |
| AtriCure (ATRC) | United States | $1.403B | 0.00 |
| Owens & Minor (OMI) | United States | $1.237B | 9.55 |
| BioLife Solutions (BLFS) | United States | $1.187B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.110B | 0.00 |
| Evolus (EOLS) | United States | $1.037B | 0.00 |
| PetIQ (PETQ) | United States | $0.919B | 23.30 |
| Phibro Animal Health (PAHC) | United States | $0.908B | 18.83 |
| National Vision Holdings (EYE) | United States | $0.862B | 27.40 |
| Cresco Labs (CRLBF) | United States | $0.805B | 0.00 |
| Quanterix (QTRX) | United States | $0.594B | 0.00 |
| Surmodics (SRDX) | United States | $0.562B | 119.39 |
| ZimVie (ZIMV) | United States | $0.468B | 43.49 |
| VAREX IMAGING (VREX) | United States | $0.445B | 13.43 |
| Valneva SE (VALN) | France | $0.419B | 0.00 |
| Jin Medical (ZJYL) | China | $0.411B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.401B | 0.00 |
| Cerus (CERS) | United States | $0.339B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.335B | 0.00 |
| Biote (BTMD) | United States | $0.331B | 15.27 |
| OraSure Technologies (OSUR) | United States | $0.324B | 8.37 |
| Aurora Cannabis (ACB) | Canada | $0.315B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.291B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.290B | 31.08 |
| Zynex (ZYXI) | United States | $0.264B | 46.28 |
| Utah Medical Products (UTMD) | United States | $0.236B | 15.70 |
| Omeros (OMER) | United States | $0.234B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.221B | 0.00 |
| MacroGenics (MGNX) | United States | $0.213B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
| High Tide (HITI) | Canada | $0.172B | 71.33 |
| Capricor Therapeutics (CAPR) | United States | $0.162B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.154B | 20.74 |
| Brainsway (BWAY) | Israel | $0.137B | 163.80 |
| TriSalus Life Sciences (TLSI) | United States | $0.135B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.129B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.122B | 0.00 |
| Veru (VERU) | United States | $0.117B | 0.00 |
| Fonar (FONR) | United States | $0.110B | 11.15 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.101B | 24.70 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.087B | 0.00 |
| InterCure (INCR) | Israel | $0.085B | 14.31 |
| Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
| Safety Shot (SHOT) | United States | $0.076B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.076B | 0.00 |
| Modular Medical (MODD) | United States | $0.074B | 0.00 |
| MariMed (MRMD) | United States | $0.065B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.055B | 3.62 |
| Exagen (XGN) | United States | $0.050B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.041B | 0.00 |
| Apyx Medical (APYX) | United States | $0.038B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
| Nephros (NEPH) | United States | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.016B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.016B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.007B | 0.00 | |
| Sharps Technology (STSS) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 20.48 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |